These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25649487)
21. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. Frei CR; Miller ML; Lewis JS; Lawson KA; Hunter JM; Oramasionwu CU; Talbert RL J Am Board Fam Med; 2010; 23(6):714-9. PubMed ID: 21057066 [TBL] [Abstract][Full Text] [Related]
22. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Ray GT; Suaya JA; Baxter R Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783 [TBL] [Abstract][Full Text] [Related]
23. Community-Associated MRSA Infection in Remote Amazon Basin Area, Peru. García C; Astocondor L; Reyes J; Carvajal LP; Arias CA; Seas C Emerg Infect Dis; 2016 May; 22(5):921-2. PubMed ID: 27088661 [No Abstract] [Full Text] [Related]
24. Invasive community-associated MRSA infections: epidemiology and antimicrobial management. Pichereau S; Rose WE Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116 [TBL] [Abstract][Full Text] [Related]
25. Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance. Diamantis ML; Ortega-Loayza AG; Morrell DS J Am Acad Dermatol; 2011 Feb; 64(2):440-1. PubMed ID: 21238834 [No Abstract] [Full Text] [Related]
26. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related]
28. [Community acquired infections with methicillin resistant strains of Staphylococcus aureus: report of five cases]. Noriega LM; González P; Hormazábal JC; Pinto C; Canals M; Munita JM; Thompson L; Marcotti A; Pérez J; Ibáñez D; Araya P; Canals C; Vial P Rev Med Chil; 2008 Jul; 136(7):885-91. PubMed ID: 18949165 [TBL] [Abstract][Full Text] [Related]
29. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center. Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235 [TBL] [Abstract][Full Text] [Related]
30. Bacteriological profile of community-acquired pyodermas with special reference to methicillin resistant Staphylococcus aureus. Thind P; Prakash SK; Wadhwa A; Garg VK; Pati B Indian J Dermatol Venereol Leprol; 2010; 76(5):572-4. PubMed ID: 20827007 [No Abstract] [Full Text] [Related]
31. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis. Gomez EO; Jafary A; Dever LL Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926 [TBL] [Abstract][Full Text] [Related]
32. Re: Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. Khawcharoenporn T J Am Board Fam Med; 2011; 24(3):331; author reply 332-3. PubMed ID: 21551408 [No Abstract] [Full Text] [Related]
33. Minocycline for the treatment of community-acquired Staphylococcus aureus infections. Gelfand MS; Mazumder SA; Cleveland KO Int J Antimicrob Agents; 2014 Apr; 43(4):385-6. PubMed ID: 24613609 [No Abstract] [Full Text] [Related]
34. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies. Krause KM; Barriere SL; Kitt MM; Benton BM Diagn Microbiol Infect Dis; 2010 Oct; 68(2):181-5. PubMed ID: 20846593 [TBL] [Abstract][Full Text] [Related]
35. A community-acquired methicillin-resistant Staphylococcus aureus lip abscess with multiple septic pulmonary emboli. Ohashi Y; Takeuchi J; Minamikawa T; Fukumoto T; Oka M Eur J Dermatol; 2021 Apr; 31(2):275-277. PubMed ID: 32540835 [No Abstract] [Full Text] [Related]
37. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Marcinak JF; Frank AL Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212 [TBL] [Abstract][Full Text] [Related]
38. Dermatologists' perceptions and practices related to community-associated methicillin-resistant Staphylococcus aureus infections. Brinsley-Rainisch KJ; Cochran RL; Pearson ML Am J Infect Control; 2008 Nov; 36(9):668-71. PubMed ID: 18834745 [TBL] [Abstract][Full Text] [Related]
39. Comparative whole genome sequencing of community-associated methicillin-resistant Staphylococcus aureus sequence type 8 from primary care clinics in a Texas community. Lee GC; Long SW; Musser JM; Beres SB; Olsen RJ; Dallas SD; Nunez YO; Frei CR Pharmacotherapy; 2015 Feb; 35(2):220-8. PubMed ID: 25644979 [TBL] [Abstract][Full Text] [Related]
40. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]